Biogen announces that the FDA has granted Breakthrough Therapy Designation to its investigational SMA drug salanersen (BIIB115).
https://finviz.com/stock?t=BIIB&p=d
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.